|
1
|
Pu Z, Zhang X, Chen Q, Yuan X and Xie H:
Establishment of an expression platform of OATP1B1 388GG and 521CC
genetic polymorphism and the therapeutic effect of tamoxifen in
MCF-7 cells. Oncol Rep. 33:2420–2428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Børøsund E, Cvancarova M, Moore SM,
Ekstedt M and Ruland CM: Comparing effects in regular practice of
e-communication and Web-based self-management support among breast
cancer patients: Preliminary results from a randomized controlled
trial. J Med Internet Res. 16:e2952014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maass N, Schem C, Bauerschlag DO, Tiemann
K, Schaefer FW, Hanson S, Muth M, Baier M, Weigel MT, Wenners AS,
et al: Final safety and efficacy analysis of a phase I/II trial
with imatinib and vinorelbine for patients with metastatic breast
cancer. Oncology. 87:300–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Walker EM, Rodriguez AI, Kohn B, Ball RM,
Pegg J, Pocock JR, Nunez R, Peterson E, Jakary S and Levine RA:
Acupuncture versus venlafaxine for the management of vasomotor
symptoms in patients with hormone receptor-positive breast cancer:
A randomized controlled trial. J Clin Oncol. 28:634–640. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohsumi S, Shimozuma K, Ohashi Y, Takeuchi
A, Suemasu K, Kuranami M, Ohno S and Watanabe T: Subjective and
objective assessment of edema during adjuvant chemotherapy for
breast cancer using taxane-containing regimens in a randomized
controlled trial: The National surgical adjuvant study of breast
cancer 02. Oncology. 82:131–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoffman CJ, Ersser SJ, Hopkinson JB,
Nicholls PG, Harrington JE and Thomas PW: Effectiveness of
mindfulness-based stress reduction in mood, breast- and
endocrine-related quality of life and well-being in stage 0 to III
breast cancer: A randomized, controlled trial. J Clin Oncol.
30:1335–1342. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khan HM, Saxena A, Gabbidon K, Rana S and
Ahmed NU: Model-based survival estimates of female breast cancer
data. Asian Pac J Cancer Prev. 15:2893–2900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ueno T, Chow LW and Toi M: Increases in
circulating VEGF levels during COX-2 inhibitor treatment in breast
cancer patients. Biomed Pharmacother. 60:277–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Generali D, Buffa FM, Deb S, Cummings M,
Reid LE, Taylor M, Andreis D, Allevi G, Ferrero G, Byrne D, et al:
COX-2 expression is predictive for early relapse and aromatase
inhibitor resistance in patients with ductal carcinoma in situ of
the breast and is a target for treatment. Br J Cancer. 111:46–54.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brandao RD, Veeck J, Van de Vijver KK,
Lindsey P, de Vries B, van Elssen CH, Blok MJ, Keymeulen K, Ayoubi
T and Smeets HJ: A randomised controlled phase II trial of
pre-operative celecoxib treatment reveals anti-tumour
transcriptional response in primary breast cancer. Breast Cancer
Res. 15:R292013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chuah BY, Putti T, Salto-Tellez M,
Charlton A, Iau P, Buhari SA, Wong CI, Tan SH, Wong AL, Chan CW, et
al: Serial changes in the expression of breast cancer-related
proteins in response to neoadjuvant chemotherapy. Ann Oncol.
22:1748–1754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao J, Yang X, Li WT, Zhao CL and Lv SJ:
Silencing of COX-2 by RNAi modulates epithelial-mesenchymal
transition in breast cancer cells partially dependent on the PGE2
cascade. Asian Pac J Cancer Prev. 15:9967–9972. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan T, Wang L and Wang B: Collagen and
prostaglandin E2 regulate aromatase expression through the
PI3K/AKT/IKK and the MAP kinase pathways in adipose stromal cells.
Mol Med Rep. 12:4766–4772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao X, Gao C, Liu G and Hu J: MAP4K4: An
emerging therapeutic target in cancer. Cell Biosci. 6:562016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu YF, Qu GQ, Lu YM, Kong WM, Liu Y, Chen
WX and Liao XH: Silencing of MAP4K4 by short hairpin RNA suppresses
proliferation, induces G1 cell cycle arrest and induces apoptosis
in gastric cancer cells. Mol Med Rep. 13:41–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiong T, Wang M, Zhao J, Liu Q, Yang C,
Luo W, Li X, Yang H, Kristiansen K, Roy B and Zhou Y: An esophageal
squamous cell carcinoma classification system that reveals
potential targets for therapy. Oncotarget. 8:49851–49860. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen H, Li L, Yang S, Wang D, Zhong S,
Zhao J and Tang J: MicroRNA-29a contributes to drug-resistance of
breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling
pathway. Gene. 593:84–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang X, Tang J, Liu X, Zeng L, Cheng C,
Luo Y, Li L, Qin SL, Sang Y, Deng LM and Lv XB: Downregulation of
miR-129-2 by promoter hypermethylation regulates breast cancer cell
proliferation and apoptosis. Oncol Rep. 35:2963–2969. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grimholt RM, Urdal P, Klingenberg O and
Piehler AP: Rapid and reliable detection of alpha-globin copy
number variations by quantitative real-time PCR. BMC Hematol.
14:42014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bos PD, Plitas G, Rudra D, Lee SY and
Rudensky AY: Transient regulatory T cell ablation deters
oncogene-driven breast cancer and enhances radiotherapy. J Exp Med.
210:2435–2466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Datta J, Berk E, Xu S, Fitzpatrick E,
Rosemblit C, Lowenfeld L, Goodman N, Lewis DA, Zhang PJ, Fisher C,
et al: Anti-HER2 CD4(+) T-helper type 1 response is a novel immune
correlate to pathologic response following neoadjuvant therapy in
HER2-positive breast cancer. Breast Cancer Res. 17:712015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng L, Ma H, Chang L, Zhou X, Wang N,
Zhao L, Zuo J, Wang Y, Han J and Wang G: Role of microRNA-141 in
colorectal cancer with lymph node metastasis. Exp Ther Med.
12:3405–3410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Onguru O, Casey MB, Kajita S, Nakamura N
and Lloyd RV: Cyclooxygenase-2 and thromboxane synthase in
non-endocrine and endocrine tumors: A review. Endocr Pathol.
16:253–277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jana D, Sarkar DK, Maji A, Chikkala BR,
Hassanujjaman S, Mukhopadhyay M and Ganguly S: Can
cyclo-oxygenase-2 be a useful prognostic and risk stratification
marker in breast cancer? J Indian Med Assoc. 110:429–433.
2012.PubMed/NCBI
|
|
25
|
Olesch C, Sha W, Angioni C, Sha LK, Açaf
E, Patrignani P, Jakobsson PJ, Radeke HH, Grösch S, Geisslinger G,
et al: MPGES-1-derived PGE2 suppresses CD80 expression on
tumor-associated phagocytes to inhibit anti-tumor immune responses
in breast cancer. Oncotarget. 6:10284–10296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thakur A, Schalk D, Tomaszewski E,
Kondadasula SV, Yano H, Sarkar FH and Lum LG: Microenvironment
generated during EGFR targeted killing of pancreatic tumor cells by
ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2
dependent pathway. J Transl Med. 11:352013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Z, Shi T, Zhou Q, et al: miR-141
regulates colonic leukocytic trafficking by targeting CXCL12β
during murine colitis and human Crohn's disease. Gut. 63:1247–1257.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan L, Jiang R, Yang Y, Ding S and Deng
H: 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer
cell line MCF-7 and downregulates cytochrome P4501B1 through the
COX-2/PGE2 pathway. Oncol Rep. 28:2131–2137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Menetrier-Caux C, Bain C, Favrot MC, Duc A
and Blay JY: Renal cell carcinoma induces interleukin 10 and
prostaglandin E2 production by monocytes. Br J Cancer. 79:119–130.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Razmkhah M, Jaberipour M, Erfani N,
Habibagahi M, Talei AR and Ghaderi A: Adipose derived stem cells
(ASCs) isolated from breast cancer tissue express IL-4, IL-10 and
TGF-β1 and upregulate expression of regulatory molecules on T
cells: Do they protect breast cancer cells from the immune
response? Cell Immunol. 266:116–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang C, He L, He P, Liu Y, Wang W, He Y,
Du Y and Gao F: Increased drug resistance in breast cancer by
tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling
pathway. Med Oncol. 32:3522015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saito S, Thuc LC, Teshima Y, et al:
Glucose fluctuations aggravate cardiac susceptibility to
ischemia/reperfusion injury by modulating microRNAs expression.
Circ J. 80:186–195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma M and Baumgartner M: Morphed and
moving: TNFα-driven motility promotes cell dissemination through
MAP4K4-induced cytoskeleton remodeling. Microb Cell. 1:154–157.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen S, Li X, Lu D, Xu Y, Mou W, Wang L,
Chen Y, Liu Y, Li X and Li LY: SOX2 regulates apoptosis through
MAP4K4-survivin signaling pathway in human lung cancer cells.
Carcinogenesis. 35:613–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
